Chengnan Huang, PhD, MS

Postdoctoral Scholar

chengnan.huang@ucsf.edu

View Full UCSF Profile

Biography

Antibody engineering and multi-specific antibody (drug conjugate) development for cancer therapy

Role

Postdoc

Category

Research

Education

PhD, 06/2023 - Biology, Tsinghua University

MS, 08/2017 - Pharmaceutical biotechnology, Wageningen University & Research

07/2017 - Glycoscience, National Institute for Bioprocessing Research and Training

BS, 06/2014 - Biotechnology, China Agricultural University

Publications

Quantifying Protein Shape to Elucidate Its Influence on Solution Viscosity in High-Concentration Electrolyte Solutions.

Tian Z, Jiang X, Chen Z, Huang C, Qian F

A bioengineered anti-VEGF protein with high affinity and high concentration for intravitreal treatment of wet age-related macular degeneration.

Huang C, Wang Y, Huang J, Liu H, Chen Z, Jiang Y, Chen Y, Qian F

Polymorphic nanobody crystals as long-acting intravitreal therapy for wet age-related macular degeneration.

Zhu S, Fan S, Tang T, Huang J, Zhou H, Huang C, Chen Y, Qian F

Multivalent nanobodies with rationally optimized linker and valency for intravitreal VEGF neutralization

Huang C, Huang J, Zhu S, Tang T, Chen Y, Qian F

Spray-Dried Monoclonal Antibody Suspension for High-Concentration and Low-Viscosity Subcutaneous Injection.

Huang C, Chen L, Franzen L, Anderski J, Qian F

Hypoxia Alters Epigenetic and N-Glycosylation Profiles of Ovarian and Breast Cancer Cell Lines in-vitro.

Greville G, Llop E, Huang C, Creagh-Flynn J, Pfister S, O'Flaherty R, Madden SF, Peracaula R, Rudd PM, McCann A, Saldova R